1. Home
  2. BCBP vs FATE Comparison

BCBP vs FATE Comparison

Compare BCBP & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCBP
  • FATE
  • Stock Information
  • Founded
  • BCBP 2000
  • FATE 2007
  • Country
  • BCBP United States
  • FATE United States
  • Employees
  • BCBP N/A
  • FATE N/A
  • Industry
  • BCBP Savings Institutions
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BCBP Finance
  • FATE Health Care
  • Exchange
  • BCBP Nasdaq
  • FATE Nasdaq
  • Market Cap
  • BCBP 136.5M
  • FATE 116.5M
  • IPO Year
  • BCBP N/A
  • FATE 2013
  • Fundamental
  • Price
  • BCBP $8.21
  • FATE $1.65
  • Analyst Decision
  • BCBP Hold
  • FATE Hold
  • Analyst Count
  • BCBP 2
  • FATE 6
  • Target Price
  • BCBP $9.50
  • FATE $3.30
  • AVG Volume (30 Days)
  • BCBP 65.5K
  • FATE 3.1M
  • Earning Date
  • BCBP 10-17-2025
  • FATE 11-11-2025
  • Dividend Yield
  • BCBP 8.12%
  • FATE N/A
  • EPS Growth
  • BCBP N/A
  • FATE N/A
  • EPS
  • BCBP 0.19
  • FATE N/A
  • Revenue
  • BCBP $65,498,000.00
  • FATE $8,470,000.00
  • Revenue This Year
  • BCBP $23.31
  • FATE N/A
  • Revenue Next Year
  • BCBP $6.72
  • FATE N/A
  • P/E Ratio
  • BCBP $41.25
  • FATE N/A
  • Revenue Growth
  • BCBP N/A
  • FATE N/A
  • 52 Week Low
  • BCBP $7.54
  • FATE $0.66
  • 52 Week High
  • BCBP $14.04
  • FATE $3.50
  • Technical
  • Relative Strength Index (RSI)
  • BCBP 47.19
  • FATE 67.82
  • Support Level
  • BCBP $7.87
  • FATE $1.42
  • Resistance Level
  • BCBP $8.16
  • FATE $1.58
  • Average True Range (ATR)
  • BCBP 0.20
  • FATE 0.16
  • MACD
  • BCBP 0.00
  • FATE 0.00
  • Stochastic Oscillator
  • BCBP 55.82
  • FATE 89.53

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: